GE HealthCare Technologies insider trading
GEHCfinancial statementsForm 4 filings on EDGAR157 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at GE HealthCare Technologies bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was an award by Grogan William K on September 14, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 16, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
157 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Grogan William K | Chief Financial Officer | award | 62,256 | $0.00 | — | 62,256 | Sep 16, 2026 |
| Sep 14, 2026 | Grogan William K | Chief Financial Officer | award | 12,840 | $0.00 | — | 75,096 | Sep 16, 2026 |
| Sep 3, 2026 | Rackliffe Philip | CEO, AIS | tax withholding | 798 | $70.56 | $56K | 41,533 | Sep 4, 2026 |
| Sep 3, 2026 | O'Neill Kevin Michael | CEO, PDx | tax withholding | 718 | $70.56 | $51K | 32,026 | Sep 4, 2026 |
| Sep 3, 2026 | Newcomb George A. | Chief Accounting Officer | tax withholding | 112 | $70.56 | $8K | 10,515 | Sep 4, 2026 |
| Sep 3, 2026 | Kass-Hout Taha | Chief Technology Officer | tax withholding | 1,502 | $70.56 | $106K | 88,467 | Sep 4, 2026 |
| Sep 3, 2026 | Jimenez Frank R | GC & Corporate Secretary | tax withholding | 1,480 | $70.56 | $104K | 89,321 | Sep 4, 2026 |
| Sep 3, 2026 | Holton Adam Y | Chief People Officer | tax withholding | 673 | $70.56 | $47K | 19,533 | Sep 4, 2026 |
| Sep 3, 2026 | Estrampes Catherine | Chief Commer. & Growth Officer | tax withholding | 508 | $70.56 | $36K | 23,573 | Sep 4, 2026 |
| Sep 3, 2026 | Arduini Peter J | President and CEO, Director | tax withholding | 6,303 | $70.56 | $445K | 241,606 | Sep 4, 2026 |
| Sep 1, 2026 | Rackliffe Philip | CEO, AIS | tax withholding | 290 | $71.23 | $21K | 42,897 | Sep 3, 2026 |
| Sep 1, 2026 | Rackliffe Philip | CEO, AIS | tax withholding | 226 | $71.23 | $16K | 42,671 | Sep 3, 2026 |
| Sep 1, 2026 | Rackliffe Philip | CEO, AIS | tax withholding | 340 | $71.23 | $24K | 42,331 | Sep 3, 2026 |
| Sep 1, 2026 | Kass-Hout Taha | Chief Technology Officer | tax withholding | 1,644 | $71.23 | $117K | 91,265 | Sep 3, 2026 |
| Sep 1, 2026 | Kass-Hout Taha | Chief Technology Officer | tax withholding | 1,296 | $71.23 | $92K | 89,969 | Sep 3, 2026 |
| Sep 1, 2026 | Jimenez Frank R | GC & Corporate Secretary | tax withholding | 1,751 | $71.23 | $125K | 92,181 | Sep 3, 2026 |
| Sep 1, 2026 | Jimenez Frank R | GC & Corporate Secretary | tax withholding | 1,380 | $71.23 | $98K | 90,801 | Sep 3, 2026 |
| Sep 1, 2026 | Holton Adam Y | Chief People Officer | tax withholding | 659 | $71.23 | $47K | 20,206 | Sep 3, 2026 |
| Sep 1, 2026 | Bankes Jeannette | CEO, Patient Care Solutions | tax withholding | 1,064 | $71.23 | $76K | 37,293 | Sep 3, 2026 |
| Sep 1, 2026 | Arduini Peter J | President and CEO, Director | tax withholding | 6,043 | $71.23 | $430K | 253,381 | Sep 3, 2026 |
| Sep 1, 2026 | Arduini Peter J | President and CEO, Director | tax withholding | 5,472 | $71.23 | $390K | 247,909 | Sep 3, 2026 |
| Aug 15, 2026 | Holton Adam Y | Chief People Officer | tax withholding | 1,360 | $73.69 | $100K | 20,865 | Aug 18, 2026 |
| May 22, 2026 | Lobo Kevin | Director | open-market buy | 10,000 | $64.18 | $642K | 14,363 | May 26, 2026 |
| May 15, 2026 | Rackliffe Philip | CEO, AIS | award | 16,458 | $0.00 | — | 43,187 | May 19, 2026 |
| May 15, 2026 | Bankes Jeannette | CEO, Patient Care Solutions | tax withholding | 5,535 | $62.67 | $347K | 38,357 | May 19, 2026 |
| May 12, 2026 | Hochman Rodney F | Director | open-market buyindirect | 1,618 | $62.03 | $100K | 1,618 | May 13, 2026 |
| May 8, 2026 | Yang Watkin Phoebe L. | Director | open-market buy | 1,000 | $63.01 | $63K | 13,702 | May 11, 2026 |
| May 7, 2026 | Yang Watkin Phoebe L. | Director | award | 3,586 | $0.00 | — | 12,702 | May 11, 2026 |
| May 7, 2026 | Culp H Lawrence JR | Director | award | 3,586 | $0.00 | — | 16,285 | May 11, 2026 |
| May 7, 2026 | Culp H Lawrence JR | Director | award | 4,157 | $0.00 | — | 20,442 | May 11, 2026 |
| May 7, 2026 | Hochman Rodney F | Director | award | 3,586 | $0.00 | — | 17,197 | May 11, 2026 |
| May 7, 2026 | Hochman Rodney F | Director | award | 2,689 | $0.00 | — | 19,886 | May 11, 2026 |
| May 7, 2026 | Lesjak Catherine A | Director | award | 3,586 | $0.00 | — | 12,702 | May 11, 2026 |
| May 7, 2026 | Lobo Kevin | Director | award | 3,586 | $0.00 | — | 4,363 | May 11, 2026 |
| May 7, 2026 | Madden Anne T | Director | award | 3,586 | $0.00 | — | 17,197 | May 11, 2026 |
| May 7, 2026 | Madden Anne T | Director | award | 2,282 | $0.00 | — | 19,479 | May 11, 2026 |
| May 7, 2026 | Stromberg William J | Director | award | 3,586 | $0.00 | — | 18,916 | May 11, 2026 |
| May 6, 2026 | Culp H Lawrence JR | Director | open-market buyindirect | 80,805 | $61.88 | $5M | 151,207 | May 7, 2026 |
| May 6, 2026 | Stromberg William J | Director | open-market buy | 1,000 | $61.69 | $62K | 15,330 | May 7, 2026 |
| May 1, 2026 | Saccaro James | Chief Financial Officer | open-market buy | 3,310 | $60.60 | $201K | 87,471 | May 1, 2026 |
| Apr 30, 2026 | Jimenez Frank R | GC & Corporate Secretary | open-market buy | 1,750 | $60.45 | $106K | 93,932 | Apr 30, 2026 |
| Apr 30, 2026 | Arduini Peter J | President and CEO, Director | open-market buy | 4,169 | $59.92 | $250K | 259,424 | Apr 30, 2026 |
| Mar 13, 2026 | Lobo Kevin | Director | award | 777 | $0.00 | — | 777 | Mar 17, 2026 |
| Mar 2, 2026 | Bankes Jeannette | CEO, Patient Care Solutions | award | 6,861 | $0.00 | — | 43,892 | Mar 4, 2026 |
| Mar 2, 2026 | Jimenez Frank R | GC & Corporate Secretary | award | 10,915 | $0.00 | — | 92,182 | Mar 4, 2026 |
| Mar 2, 2026 | Kass-Hout Taha | Chief Technology Officer | award | 13,254 | $0.00 | — | 92,909 | Mar 4, 2026 |
| Mar 2, 2026 | Holton Adam Y | Chief People Officer | award | 5,457 | $0.00 | — | 22,225 | Mar 4, 2026 |
| Mar 2, 2026 | Newcomb George A. | Chief Accounting Officer | award | 1,309 | $0.00 | — | 10,627 | Mar 4, 2026 |
| Mar 2, 2026 | O'Neill Kevin Michael | CEO, PDx | award | 6,549 | $0.00 | — | 32,744 | Mar 4, 2026 |
| Mar 2, 2026 | Rackliffe Philip | CEO, AVS | award | 9,356 | $0.00 | — | 26,729 | Mar 4, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Culp H Lawrence JR | Director | May 7, 2026 | award | 16,285 | $5M (1) | — | — |
| Lobo Kevin | Director | May 22, 2026 | open-market buy | 14,363 | $642K (1) | — | — |
| Arduini Peter J | President and CEO, Director | Sep 3, 2026 | tax withholding | 241,606 | $250K (1) | — | — |
| Saccaro James | Chief Financial Officer | May 1, 2026 | open-market buy | 87,471 | $201K (1) | — | — |
| Jimenez Frank R | GC & Corporate Secretary | Sep 3, 2026 | tax withholding | 89,321 | $106K (1) | — | — |
| Hochman Rodney F | Director | May 12, 2026 | open-market buy | 17,197 | $100K (1) | — | — |
| Yang Watkin Phoebe L. | Director | May 8, 2026 | open-market buy | 13,702 | $63K (1) | — | — |
| Stromberg William J | Director | May 7, 2026 | award | 18,916 | $62K (1) | — | — |
| Rott Roland | CEO, Imaging | Mar 2, 2026 | award | 41,082 | — | — | — |
| Rackliffe Philip | CEO, AIS | Sep 3, 2026 | tax withholding | 41,533 | — | — | — |
| Kass-Hout Taha | Chief Technology Officer | Sep 3, 2026 | tax withholding | 88,467 | — | — | — |
| Newcomb George A. | Chief Accounting Officer | Sep 3, 2026 | tax withholding | 10,515 | — | — | — |
| O'Neill Kevin Michael | CEO, PDx | Sep 3, 2026 | tax withholding | 32,026 | — | — | — |
| Holton Adam Y | Chief People Officer | Sep 3, 2026 | tax withholding | 19,533 | — | — | — |
| Stacherski Kenneth R. | Chief Enterprise Oper. Officer | Sep 1, 2025 | tax withholding | 41,430 | — | — | — |
| Bankes Jeannette | CEO, Patient Care Solutions | Sep 1, 2026 | tax withholding | 37,293 | — | — | — |
| Madden Anne T | Director | May 7, 2026 | award | 17,197 | — | — | — |
| Westrick Thomas J. | CEO, Patient Care Solutions | Mar 3, 2025 | award | 18,501 | — | — | — |
| Grogan William K | Chief Financial Officer | Sep 14, 2026 | award | 62,256 | — | — | — |
| Lesjak Catherine A | Director | May 7, 2026 | award | 12,702 | — | — | — |
| Estrampes Catherine | Chief Commer. & Growth Officer | Sep 3, 2026 | tax withholding | 23,573 | — | — | — |
| Lavizzo-Mourey Risa J | Director | May 28, 2025 | award | 10,157 | — | — | — |
| Howell Lloyd JR | Director | May 28, 2025 | award | 9,116 | — | — | — |
| Mihaljevic Tomislav | Director | May 28, 2025 | award | 9,116 | — | — | — |
Questions
Are GE HealthCare Technologies insiders buying or selling?
Over the twelve months to November 1, 2026, no insider at GE HealthCare Technologies sold stock in the open market, and 8 insiders bought $6M, all by officers and directors. Net, insiders bought $6M. Only open-market purchases and sales are counted.
Who sold the most GE HealthCare Technologies stock in the last year?
No insider sold GE HealthCare Technologies stock in the open market in the twelve months to November 1, 2026.
Do GE HealthCare Technologies executives sell under 10b5-1 plans?
There were no open-market sales in the last twelve months.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on GE HealthCare Technologies
- GE HealthCare Technologies financial statements
- 1 tracked fund holding GEHC
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.